SCHEMBL401482

SCHEMBL401482

COC(=O)c1cc(C)c(OC(=O)CCCc2ccc(NC(=O)c3ccc(C)nc3-c3ccc(C(F)(F)F)cc3)c(C(=O)N(C)C)c2)c(Cl)c1.O=S(=O)(O)c1ccccc1

nearest known ligand 0.35

Known targets — ChEMBL curated mechanism

BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.35
NTRK2 Q16620 1/20 0.35
MTTP P55157 3/20 0.32
ACLY P53396 1/20 0.32
HSPH1 Q92598 1/20 0.32
KCNH2 Q12809 1/20 0.31
PPARG P37231 2/20 0.31
PPARA Q07869 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
PPARD Q03181 1/20 0.30
NR1H4 Q96RI1 1/20 0.30
PLK1 P53350 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL399590 0.95 NTRK1 (0.35) NTRK1NTRK2KCNH2PPARGPPARA
SCHEMBL402646 0.95 NTRK1 (0.38) NTRK1NTRK2MTTPACLYHSPH1
SCHEMBL401988 0.94 NTRK1 (0.39) NTRK1NTRK2MTTPHSPH1KCNH2
Hydrochloric Acid SCHEMBL401987 0.93 NTRK1 (0.39) NTRK1NTRK2MTTPHSPH1KCNH2
SCHEMBL403306 0.92 NTRK1 (0.34) NTRK1NTRK2ACLYHSPH1KCNH2
SCHEMBL5318139 0.89 NTRK1 (0.40) NTRK1NTRK2MTTPHSPH1KCNH2
SCHEMBL403346 0.89 NTRK1 (0.42) NTRK1NTRK2MTTPHSPH1KCNH2
SCHEMBL401200 0.89 NTRK1 (0.40) NTRK1NTRK2MTTPHSPH1KCNH2
SCHEMBL403292 0.88 NTRK1 (0.39) NTRK1NTRK2HSPH1KCNH2PPARG
SCHEMBL397835 0.88 NTRK1 (0.39) NTRK1NTRK2MTTPHSPH1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US claimed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA NTRK1 3420/4885NTRK2 2775/4885MTTP 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.